SUMMARY
- Triplemoon raised $4 million in seed extension funding.
- The funds will support clinic partnerships and team growth.
- Triplemoon provides virtual mental health services for children.
Triplemoon, a Dallas, TX-based provider of virtual mental health services in partnership with pediatric clinics, has raised $4 million in a seed extension funding round, bringing total Seed funding to $7.5 million.
The round was co-led by LiveOak Ventures and Activate Venture Partners.
The company will use the funding to support demand from new clinic partnerships, expand its technology-enabled clinical protocols and proprietary tools, and hire more employees across its behavioral health and clinic success teams.
What is Triplemoon?
Founded in 2023, Triplemoon provides virtual behavioral health services in partnership with pediatricians, and family medicine practices.
Read More:Lumbra Secures $25M in Series A Funding
The company aims to make evidence-based mental health care more accessible to children and families. Its services are integrated into primary care settings, allowing families to receive behavioral health support through their existing healthcare providers.
Triplemoons AI-enabled platform helps coordinate care for patients, primary care providers, and clinical teams. Its services are designed to support children and families while helping healthcare providers manage their workloads and improve care delivery.
The company works with insurance plans, including Medicaid, to make its services accessible to more families.
RECOMMENDED FOR YOU
[Funding news] CA-based Cowbell Raises $60 Million in Series C Round Funding
Devin Jacobs
Jul 26, 2024
[Funding alert] GA-based DeFi Startup Umoja Secures $2M in Funding
Devin Jacobs
Jan 10, 2024
How Much Funding Has Triplemoon Raised?
Triplemoon has raised $7.5 million in total Seed funding, including its latest $4 million seed extension.
The company has not disclosed details of its earlier Seed funding round or its previous investors.
Who Invested in Triplemoon’s Seed Extension?
The $4 million seed extension was co-led by:
- LiveOak Ventures
- Activate Venture Partners
Krishna Srinivasan of LiveOak Venture Partners also commented on the investment, highlighting the company's focus on combining evidence-based clinical processes with technology to improve the experience for patients, providers and clinicians.
Why the Funding Matters
Triplemoon will use the funding to meet growing demand for its clinic partnerships and improve its technology-enabled care services.
The company plans to expand its clinical protocols and proprietary tools while increasing headcount, particularly across its behavioral health and clinic success teams.
Who founded Triplemoon?
Triplemoon was founded in 2023 by Lauren Gage. The company is based in Dallas, Texas.
"We are deeply grateful to our pediatric partners, patients and clinical team members who have trusted us with their care and grown alongside us over the past year. Your feedback is reflected in our strategic roadmap and this investment will allow Triplemoon to build even deeper clinical protocols to deliver exceptional experiences across each age, stage, and diagnosis in our care. We believe pediatrics is the most important population we could serve - there is no better time to be building in this space," said Lauren Gage, Founder & CEO of Triplemoon.
Market and Business Growth
Triplemoon is expanding its partnerships with pediatric clinics and family medicine practices.
The company plans to focus on independent practices in its primary markets as demand for clinic partnerships grows. Its model brings behavioral health services into existing healthcare settings, helping providers offer mental health support alongside primary care.
What Happens Next?
Triplemoon plans to expand its clinic partnerships and strengthen its technology and clinical processes.
The company will also grow its behavioral health and clinic success teams to support more practices and families. Its focus remains on making integrated pediatric mental health care more accessible through primary care providers.







